Developing a Live Attenuated RSV Vaccine for Infants & Toddlers

Time: 11:00 am
day: Pre-Conference Focus Day: Respiratory Infectious Disease Vaccine Development


  • Recent advances in the understanding of RSV gene function and reverse genetics have led to the rational design of promising new-generation replication-competent live attenuated RSV vaccines
  • Live attenuated RSV vaccines do not cause enhanced disease
  • Live attenuated RSV vaccines are expected to induce innate immunity, durable local and systemic immunity
  • Development of a live attenuated RSV vaccine could substantially reduce the global burden of disease in infants and toddlers